Propranolol for intractable diffuse lymphangiomatosis

New England Journal of Medicine

Volumn 364, Issue 14, 2011, Pages 1380-1382

  Ozeki, Michio ^a   Fukao, Toshiyuki ^a   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; ENDOTHELIAL CELL GROWTH FACTOR; GLUCOCORTICOID; INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; PEGINTERFERON; PROPRANOLOL; VASCULOTROPIN A;

ADOLESCENT; APOPTOSIS; CASE REPORT; CHYLOTHORAX; DEPRESSION; DRUG DOSE INCREASE; FEVER; HEADACHE; HUMAN; INTRACTABLE DIFFUSE LYMPHANGIOMATOSIS; LETTER; LYMPHANGIOMATOSIS; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME; THORAX RADIOGRAPHY; BLOOD; DRUG ANTAGONISM; LUNG; LUNG TUMOR; LYMPHANGIOMA; PATHOLOGY; RADIOGRAPHY;

ADOLESCENT; CHYLOTHORAX; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHANGIOMA; MALE; PROPRANOLOL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953804126     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1013217     Document Type: Letter

References (5)

1. Alvarez OA, Kjellin I, Zuppan CW. Thoracic lymphangiomatosis in a child. J Pediatr Hematol Oncol 2004;26:136-41. (Pubitemid 38186276)
2. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
3. Ozeki M, Funato M, Kanda K, et al. Clinical improvement of diffuse lymphangiomatosis with pegylated interferon alfa-2b therapy: case report and review of the literature. Pediatr Hematol Oncol 2007;24:513-24. (Pubitemid 47360010)
4. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611. (Pubitemid 39099316)
5. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997;67:353-66. (Pubitemid 27509471)